Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations (2013 - 2025)

Corbus Pharmaceuticals Holdings' Cash from Operations history runs 13 years deep, the most recent figure standing at 15550000.0 for Q3 2025.

• In Q3 2025, Cash from Operations fell 11.53% year-over-year to 15550000.0; the TTM figure through Sep 2025 stood at 59512000.0 (down 61.45% YoY), while the FY2024 annual figure was 41794000.0, down 15.77% from the prior year.
• Cash from Operations was 15550000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, up from 16599000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 856954.0 in Q3 2021 to a low of 21809505.0 in Q1 2021.
• Historically, Cash from Operations has averaged 11168006.95 across 5 years, with a median of 10615350.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Cash from Operations soared 103.14% in 2021, then slumped 945.44% in 2022.
• A 5-year view of Cash from Operations shows it stood at 9702575.0 in 2021, then advanced by 23.16% to 7454985.0 in 2022, then increased by 19.41% to 6008000.0 in 2023, then slumped by 82.12% to 10942000.0 in 2024, then slumped by 42.11% to 15550000.0 in 2025.
• The last three Cash from Operations figures came in at 15550000.0 (Q3 2025), 16599000.0 (Q2 2025), and 16421000.0 (Q1 2025), per Business Quant data.